Mulmit

Neuphoria Therapeutics Inc.Neuphoria Therapeutics Inc.

NEUP Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2026-06-301,174,165-16,451,066-13,451,931-3.06
2025-06-3015,649,448-1,129,091-369,632-0.23

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-01-20Wilson David Ian8,537
2026-01-20Fisher Alan17,073
2026-01-20Davies Peter Miles Winston8,537
2026-01-20Ryan Jane8,537
2025-10-21Lynx1 Capital Management LP639,110
2025-08-27Papapetropoulos SpyrosPresident and CEO34,559
2025-04-16Papapetropoulos SpyrosPresident and CEO270,000
2025-04-16Davies Peter Miles Winston6,783
2025-04-16Ryan Jane6,783
2025-04-16Wilson David Ian6,783
2025-04-16Fisher Alan13,566

8-K events

FiledItems
2026-07-24Entry into a material agreement · Change in control · Regulation FD disclosure · Financial statements and exhibits
2026-05-26Other events
2026-01-08Entry into a material agreement · Termination of a material agreement · Financial statements and exhibits
2025-12-18Delisting or listing-standard notice
2025-12-17Submission of matters to a vote
2025-10-27Entry into a material agreement · Material modification to rights of security holders · Amendments to charter or bylaws · Other events · Financial statements and exhibits
2025-10-20Other events · Financial statements and exhibits
2025-09-16Delisting or listing-standard notice · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.